
Venezuelans living in exile in Spain celebrated the capture of the authoritarian Venezuelan President Nicolás Maduro in Madrid.
Spanish media estimated their number to be several hundred, as they sang songs of joy and prayed the Lord's Prayer together, as could be seen on television. Many people at the famous Puerta del Sol square wept with happiness and embraced each other.
However, some of the Venezuelans expressed concern in interviews with the state-owned Spanish TV channel RTVE, as it was completely unclear how things might proceed in the South American country, they said.
"Between euphoria and caution," one woman described her reaction.
Many also expressed fear for relatives back home.
According to RTVE, almost half a million Venezuelans live in Spain. Most have left their homeland due to the authoritarian leadership in Caracas and the precarious economic and social situation.
On the Canary Island of Tenerife, however, there was a small demonstration by supporters of Maduro and his government. They held up a banner with the words "Yankees out of Venezuela and the Caribbean."
LATEST POSTS
- 1
Last supermoon of the year, the cold moon, seen across the U.S.: See the photos - 2
Promising Speculation Bearings for Portfolio Development in 2024 - 3
Manual for Wonderful Getaway destination - 4
Cyber Monday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows - 5
Share your pick for the miniature headphones that you generally suggest!
Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
What is the 'Survivor 50' Challenge? Hidden immunity idols will be up for grabs in every U.S. state.
Motivational Travel Objections for History Buffs
Overlooked infertility care should be part of national health services, says WHO
Former GLP-1 users regain lost weight after about 18 months, study says
Vote In favor of Your Number one Savvy Beds
Ukraine to get up to 100 French-made Rafale fighter jets
Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug












